Results 11 to 20 of about 59,082 (309)
Acta Dermato-Venereologica, 2023 Botulinum toxin type A (Botox®) is thought to have antipruritic effects through inhibition of pruritic factors, including acetylcholine, substance P, and glutamate. The aim of this randomized, single-blind, placebo-controlled trial was to test the effect
Leigh A. Nattkemper +7 more
doaj +1 more source
The Effects of Botulinum Toxin (BTXA) Dermal Injections on Facial Wrinkle Lines. [PDF]
Archives of Aesthetic Plastic Surgery, 2013 Facial rejuvenation using Botulinum toxin A is one of the most popular aesthetic procedures. Many cosmetic applications of Botulinum toxin A are under evaluation.
Sung Chul Park +3 more
doaj +1 more source
eNeurologicalSci, 2021 To date, efficacy data on botulinum toxin type B (rimabotulinumtoxinB) in patients with cervical dystonia (CD) previously treated with botulinum toxin type A in a large population are lacking; thus, we aimed to evaluate type B efficacy in this patient ...
Ryuji Kaji +3 more
doaj +1 more source
Indian Journal of Dermatology, 2010 Botulinum toxin, one of the most poisonous biological substances known, is a neurotoxin produced by the bacterium Clostridium botulinum. C. botulinum elaborates eight antigenically distinguishable exotoxins (A, B, C(1), C(2), D, E, F and G). All serotypes interfere with neural transmission by blocking the release of acetylcholine, the principal ...
Nigam P, Nigam Anjana
openaire +3 more sources
The clinical features, diagnosis, and treatment of cognitive impairments in Parkinson's disease
Неврология, нейропсихиатрия, психосоматика, 2017 The review presents the data of recent studies dealing with cognitive impairments (CI) in patients with Parkinson's disease (PD) and gives their characteristics and epidemiology, the specific features of the pathogenesis and clinical manifestations, as ...
G. N. Akhmadeeva +3 more
doaj +1 more source
Annals of Movement Disorders, 2020 Objective: The aim was to assess the opinion of the movement disorder society of India members regarding the uses of botulinum toxin in clinical practice.
Ashwin K Panda, Sanjay Pandey
doaj +1 more source
Botulinum Toxin Injection for the Treatment of Upper Esophageal Sphincter Dysfunction
Toxins, 2022 Dysphagia associated with upper esophageal sphincter (UES) dysfunction remarkably affects the quality of life of patients. UES injection of botulinum toxin is an effective treatment for dysphagia. In comparison with skeletal muscles of the limb and trunk,
Pengxu Wei
doaj +1 more source
Scientific Reports, 2021 The advanced biomimetic mineralization technology was applied to protect the Botulinum neurotoxin type D, and the processing of the mineralization granule of botulinum toxin type D was successfully screened.
Shengqing Li +6 more
doaj +1 more source
Botulinum toxin type A in treatment of chronic migraine, spasticity and bruxism
Journal of Education, Health and Sport, 2023 Introduction: Nowadays, botulinum toxin has found use in many disease entities such as chronic migraine, spasticity, bruxism and many others. Among serotypes A-E, type A is mainly used in treatment.
Klaudia Kuliga +9 more
doaj +1 more source
Вестник войск РХБ защиты, 2023 Botulism is dangerous toxic infection caused by a toxin produced by the bacterium Clostridium botulinum. The mortality rate from botulism can reach 70% of all cases of illness in case of untimely initiation of treatment.
D. S. Yanov +5 more
doaj +1 more source